Clinical trials

  • QEL-005 for Diffuse cutaneous systemic sclerosis | Difficult-to-treat rheumatoid arthritis
  • OMN6 for Hospital-acquired bacterial pneumonia | Ventilator-associated bacterial pneumonia | Acinetobacter baumannii infection
  • [AL[18F]F]FAPI-74 for Non-small cell lung cancer
  • 4-FLUORO-N-[2-[4-(2-METHOXYPHENYL)PIPERAZIN-1-YL]ETHYL]-N-PYRIDIN-2-YLBENZAMIDE for Dravet syndrome | Drug-resistant focal epilepsy
  • ADCX-020 for Locally advanced or metastatic solid tumors | Solid tumor
  • Clemastine fumarate for Pitt-Hopkins syndrome
  • diclofenac sodium for Primary open-angle glaucoma | Pseudoexfoliation syndrome | Pigment dispersion syndrome | Ocular hypertension
  • Propranolol hydrochloride for Traumatic brain injury | Head injury
  • VOLRUSTOMIG for Malignant pleural mesothelioma | Esophageal squamous cell carcinoma
  • nurandociguat for Chronic kidney disease
  • vorolanib for Diabetic macular edema
  • Semaglutide for Substance use disorder (chemsex-related drugs)